首页 > 市场调查报告书 > 製药

疫苗动物用医药

市场调查报告书

商品编码

1378523

伴侣动物疫苗市场：依产品类型、按类别、按配销通路、按地区

Companion Animal Vaccine Market, By Product Type, By Species Type, By Distribution Channel, and By Region

出版日期: 2023年10月17日 | 出版商:

Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球伴侣动物疫苗市场价值将达到 33.5 亿美元，预测期内（2023-2030 年）年复合成长率为 6.8%。

报告范围		报告详情
基准年	2022年	2023年市场规模	33.5亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	6.80%	2030年市场规模预测	53.1亿美元

图 1. 2023 年伴侣动物疫苗的全球市场占有率(%)（依物种类型）

伴侣动物疫苗是给宠物（如狗和猫）给药的疫苗，以刺激其免疫反应。换句话说，伴侣动物疫苗用于改善宠物和其他动物的免疫系统功能。此外，疫苗接种可以保护伴侣动物和宠物免受多种疾病的侵害，包括细小病毒、犬瘟热、钩端螺旋体病、扁桃腺炎、扁桃体炎、猫抓病和犬窝咳。定期接种疫苗是动物保健的重要组成部分，以确保伴侣动物的健康和福祉。市场上营运的主要公司正专注于研发活动、临床试验、核准和推出用于伴侣动物治疗的新型疫苗，预计将推动全球市场的成长。

市场动态

疫苗产业的主要参与者致力于开发新型疫苗来预防新疾病，例如裂谷热、蓝舌病毒（BTV）等。此外，市场上的主要参与者都专注于动物疫苗开发的无机策略，例如合併、收购和合作。政府增加对疫苗生产和分销的投资预计将推动伴侣动物疫苗市场的成长。例如，2022年6月，活跃于全球的专门从事生物製药製造流程开发的研发公司ARTES Biotechnology、总部位于比利时的生物技术公司Q-Biologicals NV以及总部位于德国的多模式色谱技术公司instrAction GmbH ，已合作开发基于病毒样颗粒（VLP）的疫苗平台和特别适合兽医应用的稳定製剂。「Plurivax」的目的是开发一个稳定的生产平台和相匹配的高品质工艺，以实现适合多种兽用疫苗的有效且可用的综合最佳实践。因此，这种含有病毒样颗粒（VLP）的产品的上市预计将为疫苗製造商提供开发新动物疫苗的机会。

本研究的主要特点

本报告详细分析了全球伴侣动物疫苗市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率。
它还阐明了不同细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
该报告根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球伴侣动物疫苗市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、类型升级、市场经营团队和行销策略做出明智的资讯。
全球伴侣动物疫苗市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
相关人员可以透过分析全球伴侣动物疫苗市场时所使用的各种策略矩阵来促进决策。

公司简介
- Elanco Animal Health Incorporated
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck &Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, as

第10章章

参考
调查方法

简介目录

Product Code: CMI3387

The global companion animal vaccine market is estimated to be valued at US$ 3.35 Billion in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.35 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	6.80%	2030 Value Projection:	US$ 5.31 Bn

Figure 1. Global Companion Animal Vaccine Market Share (%), By Species Type, 2023

Companion animal vaccinations are those administered to pets (such as dogs and cats) to stimulate their immune responses. Companion animal vaccines, in other words, are used to improve the functioning of the immune system in pets and other animals. Moreover, vaccination can protect companion animals or pets from a variety of diseases, including parvovirus, distemper, leptospirosis, lastomycosis, psittacosis, cat scratch disease, kennel cough, and others. Routine vaccination is a vital part of animal healthcare that ensures companion animals health and well-being. Key players operating in the market are focusing on research and development activities, clinical trials, approval, and the launch of novel vaccines for the treatment of companion animals, which is expected to drive market growth globally.

Market Dynamics

The key players in the vaccine industry are focusing on the development of novel vaccines for prevention against new diseases such as rift valley fever, Bluetongue Virus (BTV), etc. Moreover, major players in the market are focusing on inorganic stratergies such as mergers, acquisitions, and collaboration for vaccine developments for veterinary applications. Increasing investments by governments to support manufacturing and distribution of vaccines is expected to propel market growth for companion animal vaccine. For instane, In June 2022, ARTES Biotechnology, a globally active Research and development company specializing in developing biopharmaceutical production processes, Q-Biologicals NV, a Belgium-based biotechnology company, and instrAction GmbH, a Germany-based multimodal chromatography technology company, partnered to collaborate on the development of a virus-like particle (VLP)-based vaccine platform and stable formulation especially suited for veterinary applications. The intent of "Plurivax" is to develop a stable production platform and an adapted, high-quality process to have an effective and usable integrated best practice suitable for several veterinary vaccines. Thus, the availability of the product in the market, which includes virus-like particles (VLP), is expected to offer opportunities for vaccine manufacturers to develop novel vaccines for veterinary use.

Key features of the study:

This report provides an in-depth analysis of the global companion animal vaccine market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global companion animal vaccine market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Elanco Animal Health Incorporated, Boehringer Ingelheim GmbH, Ceva Ltd., Merck & Co. Inc., Virbac, Zoetis Inc., HIPRA, Biogenesis Bago, Ourofino Animal Health, Croda International Plc, KM Biologics, Indian Immunologicals Ltd., Sinovac, Kyoto Biken Laboratories, Inc., HESTER BIOSCIENCES LIMITED, Calier, Bioveta, a.s
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global companion animal vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global companion animal vaccine market

Detailed Segmentation:

Global Companion Animal Vaccine Market , By Product Type:
- Attenuated Live Vaccine
- Conjugate Vaccine
- Inactivated Vaccine
- Subunit Vaccine
- Toxoid Vaccine
- DNA Vaccine
- Recombinant Vaccine
Global Companion Animal Vaccine Market , By Species Type:
- Canine
- Feline
- Equine
- Avians
- Others
Global Companion Animal Vaccine Market , By Distribution channel:
- Veterinary Clinics
- Veterinary Hospitals
- Veterinary Research Institutes
- Others
Global Companion Animal Vaccine Market , By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Elanco Animal Health Incorporated
- Boehringer Ingelheim Gmb
- Ceva Ltd.
- Merck & Co Inc.
- Virbac, Inc.
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, a.s

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Species Type
- Market Snippet, By Distribution Channel
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Product Launches/Approvals
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Companion Animal Vaccine Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Companion Animal Vaccine Market, By Product Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Attenuated Live Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Conjugate Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Inactivated Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Subunit Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Toxoid Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
DNA Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trend
Recombinant Vaccine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trend

6. Global Companion Animal Vaccine Market, By Species Type, 2018- 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Canine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Feline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Equine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Avians
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
- Segment Trends

7. Global Companion Animal Vaccine Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
Veterinary Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Veterinary Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Veterinary Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Companion Animal Vaccine Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019-2030
- Segment Trends
North America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, Y-o-Y Growth and By Product Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Species Type, 2018 -2030, (US$ Bn)
- Market Size and Forecast, Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
- Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Elanco Animal Health Incorporated
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Strategies
- Boehringer Ingelheim GmbH
- Ceva Ltd.
- Merck & Co. Inc.
- Virbac
- Zoetis Inc.
- HIPRA
- Biogenesis Bago
- Ourofino Animal Health.
- Croda International Plc
- KM Biologics
- Indian Immunologicals Ltd.
- Sinovac
- Kyoto Biken Laboratories, Inc.
- HESTER BIOSCIENCES LIMITED
- Calier
- Bioveta, a.s